Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. TSLA
3. META
4. STZ
5. INTC
6. HOOD
7. SPCX
8. GOOGL
9. FDS
10. FUTU

Go back to Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
(NASDAQ: ENSC) Delayed: 0.28 -0.02 (6.67%)
Previous Close $0.30    52 Week High $ 
Open $0.29    52 Week Low $ 
Day High $0.30    P/E N/A 
Day Low $0.28    EPS $ 
Volume 314,594